Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm not there yet either. But the longer this goes, the nail is hammering down.
Soon to be 9 months of crickets on ARS. How about getting this trial started already. What is the holdup? Sosei? If it's dead, say so. If it's not, say so. CHA? Enrolment numbers? Pretty much anything this company is involved in, shareholders are left in limbo. Should be canned for this reason alone.
It's remarkable people are ok with it. Laughable actually. Go back to selling the first aid kits on someone else's nickel.
The silence is truly deafening. I too agree ARS is the only hope. CLI will be at least 2 years away until we get half enrolled imo.
Still hoping something significant will happen soon. But either way, get these clownz outta here. Sickening.
2022. LMBO. May need to go further out. Should come out with decade timeframes. That way management may just have a shot.
We'll get em next week tiger.
Seriously though, have you seen the open interest on June $3's. 5000. Hoping someone in the know has gobbled those up. I've thought that before though only to watch the date fly by.
Exactly EichKing. Excellent at slide shows for sure as well as trade shows of course. Just keep every milestone at 12 months and it can remain indefinitely. And put check marks and then take them away. Just keep em all guessing. To bullet or not to bullet. Or just do a half assed job at it, they will eat it all up.
So CLI was updated at clinical trials website. You check that daily right Allo. Didn't want to report the lack of new sites??? Seems they have 15 sites woth 14 recruiting as of Jan 9th of this year. Pretty far cry from the 40 they were hoping for by end of '17. But ya, we will get approved this year right Allo. Makes you wonder why they applied for the compassionate use...grasping at anything.
5 out of 6 milestones missed from 2017. Include Sosei and 40 sites we can make it 1 for 8. Wow amazing!!! I'm sure there are others, but just what I recall.
How many missed milestones, promises, or anything that they give a timeframe to will it take for people to realize these guys are clownz. Yes the product could be great, but we have the twins that are so far over their heads it's crazy. Can anyone think of ONE timeframe they have made in the last 10 years. Dosing study is the ONLY one I can think of. Good job clownz.
May still pull it off, but should have been there long ago. Get a real board with an ounce of integrity that's not a spouse and get these clownz out of here. Get em back selling what they're good at...first aid kits for cars
That must be us. What's going on with your prediction of Lonza and Amgen. There were a lot of Lonza beliebers here. Maybe they'll turn to JP Morgan now that the chosen one has dreamt it up. I'll keep my eyes open for a JP office opening in Haifa. LMBO
How hard would it be for management to put out a shareholder update. We have no idea on the state of CHA, passed deadline on Sosei, 8 months of crickets since ARS dosing trial was completed. We have no HCT interim results, NYBC results, nothing. It's truly astonishing how this company keeps its shareholders in the dark.
This last news release does seem quite positive to me. I don't think the FDA would grant this, unless there is some evidence of efficacy from the ongoing study. But then again, it is compassionate use in essence, so who knows. Would be nice to get some immediate results that they could actually UPDATE the public with. They may have to eat the costs at first, with reimbursement depending on initial results.
Allo, you forgot one more thing they may have sold CHA for...to fund the summer tour. LMBO.
A cure for self pity would work wonders here to EH!
I guess from what some say here, once you invest you should never change your mind. Pretty prudent strategy.
Realization that our management is a bunch of clowns, changed many of our minds. Since I've been in this company for probably 8 years now, they touted an ever increasing interest from Pharma companies. But what have we got? Two failed partnerships with UT and Chinese, a who knows what with CHA, and an unknown, past the deadline one with Sosei. Are they just blowing smoke? Sure seems that way.
That's great management alright. Other Biotechs partner. It takes tremendous risk off the table. Sure you don't reap all the rewards, but makes it a lot easier to get to the finish line. With all the promising potential in a ton of indications, why not partner with one of them for a little less than what you want. Would have helped the share price tremendously, allowing for much greater raises without the crazy dilution.
The dilution route ismt much of an option anymore. Don't think another will happen without decimating the price and O/S.
So yes the confidence in this company has severely diminished for me in 2017. My mind has changed in the last year. The remarkable thing is it hasn't for others. Some tout a drive to own 200k. Laughable truly. In so many ways. Take a couple zeros off would be more realistic. Internet bravado to the max!!! LMBO. Have a look around, the industry is not sitting still like we seem to be. But I still believe in the technology so I will be in until the end. Kaki's should be shellakied!!!
Hey skitahoe . We all know the enormous potential for ARS. It is the management. I notice you just ignore any thoughts on that, and just post the same thing in essence.
What are your thoughts on the twins and upper management if you've looked into them at all. Hopefully you have, but your optimistic posts show otherwise.
Bunch of bozzo's thats for sure. Emailed them with regards to the passed partnership deadline. Zero response as usual. Anyone else try emailing. To busy with Bon voyage parties and pre show pep talks I guess.
Company does jack Jack, so why not complain about MORE missed things. It the one thing the clown twins are best at. Glad you're good with them. We aren't!!!
No, only idiots would want this management of circus rejects to remain. Do you want them to stay? LMBO
Dead fish. LMBO. Maybe they'll announce something Jan 8, 14, 22, Feb 7, March 15, 20. All upcoming dates for the world tour. Would be a great time to announce news. LMBO. Or come Thursday, we can give the proverbial "next week" for news. Halfway through the year it will be 2019 for the year of the shareholders. 2018 was too full of events to get anything done.
Ones that are sick of the pathetic management and want real management with real Pharma experience. Selling first aid kits for cars doesn't cut it. How anyone doesn't see this is what is truly astonishing. Ones that want change.
Some are just fine with deadline after deadline missed, zero transparency or communication. A stock price the same as it was over 7 years ago. Managements sell, at the absolute top of the run at $5. Sosei silence even though deadline passed. Fine with it all I guess.
Give the head a shake and look without the beer goggles off and the realization may set in. It's laughable truly.
Bloody incompetent pieces of crap. Deadline of Dec 31st means nothing I guess. No word. Damn coward pos's. Silence yet again. But ya, I'm good with the clowns. Anyone who thinks they are ok whatsoever, should start selling first aid kits for cars as well. Go to tons of shows, boff lots of secretaries, and gift themselves 4% of the company...you deserve it.
Happy New Years to the employees, middle finger to the shareholders. Nepotistic board won't do nothing to their buddies. They're gifted shares for gifting shares. That's what a good board should do. But I'm fine with it. Clowns clowns clowns. Go back to the circus b
Go twins go...right out the door in to the street where you deserve to be.
Hi Skitahoe,
One thing you should definitely look into is the twin clowns that many here don't want to accept. I have posted their history, along with 2 board members and they lack pretty much anything.
There are a lot of scenarios for this company. One of them is running out of cash before anything is approved. Yes ARS is the furthest advanced and pretty much the ONLY shot. Without it, chances are slim. They really only have phase 1 data on any of their trials outside ARS.
These clowns have missed deadline after deadline. Two damn years waiting for a partnership in Japan to get the "Fast track" started. We have about 24 hours for another failed partnership to happen...or another delay yet again. Will that make it 4 delays on the Sosei deal?
You want to invest, like Blue said its a gamble. But please take a look into management before you dive in blindly about the technology. Wish I did first. Many here don't care about management, but they truly are pathetic. Zero experience and that is the reason for eternal missed milestones. Experienced management would know the delays in pretty much everything. Zami's pharma experience is selling first aid kits for cars.
Their silence in pretty much everything, including holding any sort of CC ever, speaks volumes. Can't even update their only way to speak to shareholders, presentations. Or a Yaki fart at the Jerusalem Post conference. The street obviously has its doubts about this company. Hence our zero price appreciation for at least the last 7 years. But yet they gift themselves 2 million shares because they were sick of their options expiring worthless.
And let's not forget the uptick in the number of shows that occurred as soon as they got their PP.
24 hours to a major call for there heads. Except from the lemmings who belieb them. Many had given them until the end of the year that was supposed to be our year. But like always, that was delayed until 2018. Doesn't cut it for me. Can the incompetent twins ASAP. I'm hoping the Israeli investors they scammed in the latest pump lead the charge.
Only one that was achieved was the data readout for ARS. Out of the fumbling twins incapable hands was the only reason it happened. Other 5 will be missed in two more days. Pathetic.
And what's happening with Sosei. Talk about waiting until the last moment. Are they now scrambling to figure something out. They finally getting down to do some work with a lull in the shows? Nah. Just keeping an eye on the long ball for 2018...how much of a bonus they should get. Priority number one, Pluristem employees.
Yes the street knows this company is run by clowns. If it weren't for the technology and its accomplishments to date, we would be in the pennies. Who knows, maybe a cancelled Sosei deal will bring us down to just pennies, with no number to the left of the decimal.
Another failed partnership that has wasted 2 years of time in Japan, just might be the last straw for the street. It is the only thing the twins are great at...failed partnerships. But I'm good with them. LMBOx10000
I'm not sure if you actually grasp what happens when you buy a stock. You OWN a portion. In your case, tons, as you were buying above $2 and all the way down. LMBO. Glad you're good with that. I told you in the $1.60's to wait, but you couldn't resist. Should have listened...LMBO. Did you buy on yesterday's big pop?
So if someone in a company you own, is making poor decisions and missing pretty much all milestones like they have, it's astonishing you wouldn't question anything. They say nothing. Silence. That's what you should want when you're an owner of a company. It's laughable truly.
And me referring to Allo as the chosen one, is not what you say in the least. They post about Lonza or Amgen and all the lemmings come running out of the woodworks. Oh that's true. Oh that's this. Oh that's a real possibility. Pure garbage is what that is. That's what's even more laughable. So if some tool wants to think that's anti anything..so be it. It's an anti-idiots statement. You can gauge for yourself if you fit that bill too. Don't believe what Mom says. LMBOx1000.
Wow you take the cake man. Sorry your body language expertise can't help you in life.
It's idiots I have a problem with. Sorry if you fit the bill.
Where in the world did you come up with that? You're a joke.
Maybe it's just some beliebers thinking management just can't miss 5 out of 6 milestones they had in January.
Maybe management has decided to throw us a bone by selling via the ATM. That's how the chosen one thinks they support the price isn't it?
Maybe another pump is starting getting ready for the next dilution early next year. Heard some employees are complaining they didn't get to go on any world tours. Twins want all employees to reap the rewards of their hard work diluting 3 times in one year.
Maybe it will actually be the start of something. That way I can save a ton on Kleenex that I've needed for all my crying. And then I can afford to go to university to further my studies in the art of body language. Anxiously awaiting the next videos so I can pick apart any wink, nod, stutter, or toot. I don't think I said this but thank you for the inspiration Midas.
Wow we are all rich now. Thanks management.
Not a chance. A 10% gain doesn't even get us to where we were 7 years ago. Why would that make me stop? Could just be people actually beliebing the twin clowns are actually going to get something done by the end of the year. Or is that you Zzatt backing the truck up again?
Besides I've been doing a lot of body language studying in hopes of coming close to your level of expertise. And on Erik's comment that made Kaki look all weird, I've come to the conclusion it was a toot. That's why he was staring at the ceiling at one point earlier. He was checking out the ventilation system.
That's right keep averaging down. Just don't use that so called "money under the mattress". Or...maybe that's a great idea.
People complain about the three amigos saying we state the same thing over and over again. We bring new stuff quite a bit thank you. Yes much about management, but they deserve the constant jabs. They're good enough. They have others running the show. Two very successful and talented managers. If that's not one of the best statement of the year. And here I thought you were learning. LMBOx1000.
Others bring in body language reading, Lonza opening up in Israel, now a dropped show and what that means...now that's top notch research. You got to love that. Can't argue with facts.
Put us all on ignore. Escape from reality if you choose. Or have you escaped already.
"Their timelines". You're not serious are you. This company has put out a tremendous amount of timelines. Many which would probably move the price don't you think? Partners, government contracts, interim results...all missed (in a couple weeks) and ALL would effect the price.
Have they made any milestones? Only one I can think of and that was because the U.S. government was running it...the efficient ones.
Two years with getting a Japanese partner. TWO YEARS!!! And we are still not sure what is happening with that. I'll bet on a Christmas Day announcement of a cancelled Sosei deal, hoping investors won't see it. LMBO.
So we just go by what the company told us. They didn't want to have pissed off investors, they should have hired real people with realistic goals, timelines, and transparency. But those things only come with experience in this field. You know, the thing that many here don't seem to care about.
And the real kicker, a lower price 7 years later. With all the apparent progression in this company in the last 7 years, there must be something else keeping people away like the plague. It's called "the circus of misfits" in upper management and the board.
It is the COMPANIES own timelines that are missed and changed that effect our price negatively, How don't you see that, and even worse, how do you accept that?
Glad your happy with your multiple $10,000's purchases in the $1.60's, and of course the ones you bought in the $2,s during the pump. One week before the hammer came down right. Was asking someone else their opinion. They actually write stuff. At least you're now agreeing on management. But keep on buying. Hopefully you get your average price down.
Hey no_ur_stox. Glad to see your return. You like to state your positive opinions and that's fine. Not sure if you've read the last few weeks of posts since your absence. Just want to reply to your post and ask a few questions on your thoughts on our management and board. Sorry for the long post and will take a bit to get through I'm sure. But it will be worth it. We truly have clowns running this ship, and am curious what you think of our leadership after reading this.
First, you can talk about HGSI being bought out by GSK and ARIA being bought out by Takeda, but what about the many other Biotechs that aren't so fortunate. Hindsight is 20/20, and if you posted that before it happened, it would be much more impressive. Maybe you did, I don't know. I could post many companies that were bought out after the fact. That would be easy. But of it happens to Pluristem, I would be ecstatic.
But I'm sure there were many so called "bashers" on all those other companies message boards that turned out to be right. And that would be the case for any company, not just in the biotech space, as the percentage that make it or not, is highly more likely not to.
So I'm going to refer you to a few posts of mine regarding the twins and two members of our board. Just want to see your opinion considering you mentioned MESO like others have of late. I just posted their board members, but not sure if you've looked at ours.
First board member
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136912179
The next board member.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136913340
Compare them to Meso board post and let me know what you think.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136992979
Now I will give you a couple of posts on the twins. Let me know what you think of their resume.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136641266
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136772911
And look at that...they partner with JCR in Japan and they get a product approved. One we are just starting to get into. Not sure if it's the same, but they're both GvHD. Maybe they should have worked quicker on partnering in Japan. Trial would be done and would have had a marketable product by now. It's been 2 freaking years!!! But let's hold out because we can do more raises. Great job twins!!! We should now focus more on products that are approved by someone else.
JCR Pharmaceuticals Co. Ltd has been granted an exclusive right in Japan to Mesoblast’s technology for use in conjunction with the treatment for hematologic malignancies using hematopoietic stem cell transplants derived from peripheral blood, cord blood or bone marrow. JCR has received Japanese Government regulatory approval for its mesenchymal stem cell-based product for children and adults with acute graft versus host disease. TEMCELL® HS Inj. is the first allogeneic cell-based product to receive full approval in Japan
That is what they should have done a while ago n3. License one of their therapies or at least in a certain region to get enough cash so they're not having to dilute 3 different times in a year. No cash influx in the next quarter or two, we will be diluting again, but with a lot more hurt.
I'm hoping the investors in their own backyard that bought into the pump the last raise, are able to put some pressure on someone to get something done that brings value to shareholders and not employees.
Nothing like waiting until the last moment to close this Sosei deal. I really don't understand that one at all. We announce another postponement or cancellation with nothing else significant, we're going to get whacked. We'll probably get whacked if it does go through, just won't hurt as much.
And can someone please explain CHA. What is their purpose, just to show a partner for good looks? Not once since they signed that damn thing have they ever stated anything. Just a token paragraph in every quarter, that goes back many years now. Wonder if they even have shares left in Pluristem, or is they bailed as soon as hold period elapsed.
New Years is coming fast. Clock is ticking...
Since there's some discussion about Mesoblast, have a look at their directors. Management is also very good, but their board is stellar. But we should be happy with our joke of a board.
Jamieson, FCA
Non-Executive Chairman
Mr Jamieson has served on the Board of Directors as Chairman since 2007 after retiring as Chief Executive of Minter Ellison Melbourne. Previously he was CEO at KPMG Australia, a KPMG Board Member in Australia, and a member of the USA Management Committee. Mr Jamieson is Chairman of Sigma Pharmaceuticals Ltd, a Non-Executive Director of the Tatts Group Ltd, and Director and Treasurer of the Bionics Institute. He is a fellow of the Institute of Chartered Accountants in Australia.
William M. Burns, BA
Non-Executive Vice Chairman
Mr Burns has served on the Board of Directors since 2014 and was appointed Vice Chairman in 2016. He spent his entire management career at the Beecham Group and F. Hoffmann-La Roche Ltd. Mr Burns was Chief Executive Officer of Roche Pharmaceuticals from 2001 to 2009, when he joined the Board of Directors of F. Hoffmann-La Roche Ltd. until he retired in 2014. He is a Non-Executive Lead Independent Director of Shire PLC, has been a Non-Executive Director of Chugai Pharmaceutical Co., Genentech, Crucell, and Chairman of Biotie Therapies Corp. from 2014 until its sale to Acorda Therapeutics Inc. in 2016. Mr Burns is also a member of the Oncology Advisory Board of the Universities of Cologne/Bonn in Germany. In 2014, he was appointed a trustee of the Institute of Cancer Research, London, and in 2016 a Governor of The Wellcome Trust in London, UK.
MBBS, FRACP
Chief Executive Officer (Executive Director)
Dr Itescu has served on the Board of Directors since the Company's founding in 2004, was Executive Director from 2007, and became Chief Executive Officer and Managing Director in 2011. Prior to founding Mesoblast in 2004, he established an international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure. Dr Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia. In 2013, Dr Itescu received the inaugural Key Innovator Award from the Vatican’s Pontifical Council for Culture for his leadership in translational science and clinical medicine in relation to adult stem cell therapy. In 2011, he was named BioSpectrum Asia Person of the Year. Dr Itescu has consulted for various international pharmaceutical companies, has been an adviser to biotechnology and health care investor groups, and has served on the Board of Directors of several publicly-listed life sciences companies.
Donal O’Dwyer, BE, MBA
Non-Executive Director
Mr O’Dwyer has served on the Board of Directors since 2004. He has over 25 years of experience as a senior executive in the global cardiovascular and medical devices industries. From 1996 to 2003, Mr O’Dwyer worked for Cordis Cardiology, the cardiology division of Johnson & Johnson’s Cordis Corporation, initially as its president (Europe) and from 2000 as its worldwide president. Prior to joining Cordis, he worked with Baxter Healthcare, rising from plant manager in Ireland to president of the Cardiovascular Group, Europe, now Edwards Lifesciences. He is a qualified civil engineer with an MBA. Mr O’Dwyer is on the Board of Directors of a number of life sciences companies including Cochlear Ltd, Atcor Medical Holdings Ltd, Fisher & Paykel Healthcare Ltd and NIB Health Funds Ltd.
Eric Rose, MD
Non-Executive Director
Dr Rose has served on the Board of Directors since 2013. He is currently Chairman and Chief Executive Officer of SIGA Technologies and Executive Vice President, Life Sciences at MacAndrews & Forbes, Inc., the holding company of Ronald O. Perelman. From 2008 through 2012, Dr Rose served as the Edmond A. Guggenheim Professor and Chairman of the Department of Health Evidence and Policy at the Mount Sinai School of Medicine. From 1994 through 2007, he served as Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital. From 1982 through 1992, Dr Rose led the Columbia Presbyterian heart transplantation program in the United States. He currently sits on the Board of Directors of ABIOMED.
BCom, ACA
Non-Executive Director
Mr Spooner has served on the Board of Directors since 2004. During this period he has filled various roles including as Chairman from the date of the ASX public listing in 2004 until 2007, Chair of the Audit and Risk Committee as well as a member of the Remuneration Committee. Over the past several years Mr Spooner has served on the Board of Directors in various capacities at several Australian and international biotechnology companies, including BiVacor Pty Ltd (2009-2013), Advanced Surgical Design & Manufacture Limited (2010-2011), Peplin, Inc. (2004-2009), Hawaii Biotech, Inc. (2010-2012), Hunter Immunology Limited (2007-2008), and Ventracor Limited (2001-2003). Prior to returning to Australia in 2001, he spent much of his career internationally where he served in various roles including as a partner to PA Consulting Group, a United Kingdom-based management consultancy and a Principal Partner and Director of Consulting Services with PricewaterhouseCoopers (Coopers & Lybrand) in Hong Kong. In addition, Mr Spooner has owned and operated several international companies providing services and has consulted to a number of American and Asian public companies.
Ben-Zion Weiner, BSc, MSc, PhD
Non-Executive Director
Dr Weiner has served on our Board of Directors since 2012. In a 37-year career at Teva Pharmaceutical Industries Ltd, he held various senior research and development positions, including Senior Vice President of Global Research and Development. Dr Weiner twice received the Rothschild Prize for industrial innovation - for the development of Copaxone for the treatment of multiple sclerosis, and alpha D3 for kidney and bone disorders. He is on the Board of Directors at Novaremed Ltd., the scientific advisory board at E-QURE Corp. and Breed IT, Corp. and has served on the Board of Directors at Geffen Biomed Investments Ltd (2010-2013), XTL Biopharmaceuticals Limited (2012-2013) and Breed IT, Corp.
Charlie Harrison – BA, LLB (Hons)
Company Secretary
Mr Harrison joined Mesoblast as a legal counsel in 2013. He was previously a senior associate at the international law firm Allens, working in their Hong Kong and Melbourne offices for nine years as a corporate lawyer. Mr Harrison has an Arts/Law degree from the University of Melbourne. He was appointed Company Secretary in 2014.
LMBO Blue. Yes the beliebers have now started resting their hopes on body language. I was thinking more along the lines that Arik let out a gasser, and it just wafting up to big head Yami at that moment. Didn't teach that in body language 101. Or it was Yaki himself that dropped the bomb as he was shifting earlier. Some bad matzah balls from earlier coming back to haunt him. Look of shock that someone may report the pungent smell. Anyone have any Tarot cards?
Bunch of misfits sitting on boards of anyone who will take them, hoping to hit the big one. Zami could be all of their saviours with a lucky draw. Lots of geezers hoping they finally get some redemption for their careers of dozens of failed startups, pathetic mergers, and failed inventions.
That's some great timing you have in the post I'm replying to. Several multiples of $10,000 you said on the day the high was $1.75 and the low was $1.63. Or post #7785. You stated how you wished you waited until this week (post raise) to buy. So how many did you buy the week before the raise. LMBO. Anything under $2 is a gift is what you also said. Hate to see when you're off on timing.. So wow you must have bought a ton of shares earlier on if you are up. LMBO!!!
Well you did your DD first and thought they were good. LMBO. Sure I thought Pluristem looked good on the outside. But after some serious DD, they are rotten to the core.
So I see Midas you only remark on the one movement, not the 20 others the nervous, glistening Yaki did.
You wonder why the accusations I have made come about. You want to call looking into the experience of board members and management superficial? You know, the board that approved the big bonuses for the twins. I guess they are just irrelevant then huh. Just frivolous stuff I found. You don't care about any nepotism that we now know exists. Will see if I can find more spouses or immediate family members sucking on the Pluristem teat.
When you try to pawn actual stuff off as superficial, it tends to lead one to believe there could be ulterior motives. Especially when you somehow try to pawn body language reading as relevant. So another question...where did you get schooling to become this self professed expert in body language. I'd love to gain your expertise, that way I too can look for simple winks, nods, toots that surely indicate multi billion dollar possibilities. Can't wait!!! I too want to learn how not to post superficial things.
Don't know how many people follow Elbit Vision Systems, but we all know they were picked clean of management by Pluristem...unfortunately. So I guess it's just pure coincidence that you follow 2 companies that had at least 3 employees in. It's pretty obvious your blatant disregard for management of any company you invest in.
And a polite question such as if the 3d bioreactors could grow cells other than MSC's was too hard to answer. Even if they don't want to tell me in case of "company secret" at least acknowledge the email. Not too much to ask from IR is it. Apparently it is. Maybe if I threw in a Hebrew word or signed with a Hebrew name I would have gotten a response from the "club".
So again you don't want to give your expert opinion on Yaki's ceiling stare. I have emailed Karine with respectful questions, with zero response. So the chances of either twin responding is as likely as some here admitting our company is run by a bunch of clowns.
So I anxiously await your non-superficial response to Yaki's movements. Proven science so I've heard. Like you, I enjoy a laugh too.
You didn't want to respond to Yaki's awkward ceiling stare. You're the resident body language expert.
You call factual information on the pitiful resumes of the twins and management superficial. Body language is superficial. Factual information is not. Im not hitting a nerve with your Elbit Vision Systems buddies now am I, considering I'm demolishing their claims of any relevant experience.
Nope. Needs FDA approval for anyone but U.S. Government
Hi Midas. I have brought about new information, at least which o never remember being posted here, about Zami, Yaki, now 2 board members so far. How is that repetitive. Much of the repetitive banter is gone while Allo is not posting fictitious posts. We just had 10 posts on Yaki's movements.
As for why the constant bashing when we are investors in this stock. Said it repetitively. I want new management with experience. Period. Why others don't want truly baffles me. I have emailed Karine many times. Don't get a single response or even acknowledgement. So that's why that's a waste of time.
It is comical isn't it EichKing. No matter what evidence is found on many of the people in this company, many don't care. I feel like I'm in Bizzaro World. But we plug on hoping something will come that will bring value to us for a change. Not buddies that have spent their lives chasing one dream to the next, many failed companies, startups, "huge" merger and acquisitions, director appointments, monster PP's. The list is endless.